San Francisco, California, November 06, 2018: A recent market research report by TMR Research presents a scrupulous account of the growth prospects of the global market for panic disorders. The report is titled “Panic Disorders Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025.”
The market is expected to embark on a path of healthy growth in the next few years, benefitting from the rising number of drugs for panic disorders entering and passing clinical trials. The rising prevalence of panic disorders due to hectic lifestyles of people, especially in urban settings globally, and the increased focus of leading companies in the market on expanding their product portfolios are expected to be the key factors driving the market.
Get Sample Copy of this Report @
The market is also expected to benefit from the rising awareness regarding mental and anxiety disorders and the easy availability of a vast variety of drugs for panic disorders across the globe. However, the lack of awareness regarding in developing and underdeveloped economies regarding the serious impact of panic disorders on everyday lives of patients could hinder the growth of the market to a certain extent over the report’s forecast period.
From a geographical standpoint, the market in North America is envisaged to be at the forefront in terms of growth prospects and revenue contribution to the global market over the forecast period. This is chiefly owing to the high concentration of leading companies and the rising awareness regarding the available cures for a number of panic disorders among people in the region.
The market in Asia Pacific, on the other hand, will exhibit growth at a robust pace over the forecast period owing to the vast set of untapped growth opportunities in the region and the rising awareness among people. Rising disposable incomes and increased expenditure on healthcare are also expected to work well for the Asia Pacific panic disorders market in the next few years.
Read Comprehensive Overview of Report @
Some of the leading companies operating in the global panic disorders market are Sanofi, Bristol-Myers Squibb Company, GlaxoSmithKline plc, H. Lundbeck A/S, F. Hoffmann-La Roche Ltd., Actavis plc, Boehringer Ingelheim GmbH, Mylan, Inc., Eli Lilly and Company, and Pfizer, Inc.